Hideharu Shintani, PhD, Guest Professor; born in Osaka, Japan, Feb. 23, 1948; Family, Miharu Amagai, Feb. 10,1949; 2 children. Present Address, 1-10-60,Minamidaira, Hino 191-0041, Tokyo, Japan; Education, BA, Kyoto U., 1972, MS, 1974, PhD, 1977. Carrier, Researcher National Institute of Health Sciences (NIHS), Tokyo, 1977-87, Senior Researcher 1987-92, Director of Department 1992-2009, Guest Professor of Chuo University, School of Science, 2009-, Research Associate at Texas Tech University, Department of Chemistry, Lubbock, 1986-87; Academic Activity, Director of Antibacterial and Antifungal Society Japan, Editorial Board of Biocontrol Science, J. Radiation Sterilization, and Trends in Biomaterial & Artificial Organs. A Chairman of the Japanese Government Committee entitled Sterilization and inactivation of endotoxin and prion by gas plasma exposure. Book publication, Author: Bioinstrumentation and Biosensors, 1990, Ohio Science Workbook Polymers, 1994, Analytical Applications of Immobilized Enzyme Reactors, 1994, Sterilization Systems 1995, Adsorption and its Application in Industry and Environmental Protection, 1998; editor: Handbook of Analytical Application of Capillary Electrophoresis, 1996. Sterilization and Disinfection by Plasma –Sterilization Mechanisms, Biological and Medical Applications, 2011; Member AAMI, ISO (Japan Delegate 19991-). Home 1-10-60, Hino Tokyo Japan, Office: Chuo University, School of Science, Bunkyo-ku, Kasuga l-chome, 13-27, Tokyo 112-0003, Japan
1. How many years have you been practicing and/or performing research?
More than 40 years. Right now I am 66 year old.
2. What is the research topic you are working on now?
Previously analytical chemistry. Thereafter, microbiology together with analytical chemistry because I was asked to be Japanese delegate of ISO TC 198 WG 4 from Ministry of health , labor and welfare.
3. What makes an article top quality?
Splendid originality. Originality is most important.
4. What are the qualities you look for in an article?
Originality is well studied or not.
5. Do you have any research funding (NIH or other national funding) now?
I have a Japanese Government Research funds.
6. When did you become an editor of OMICS Journal?
I do not know exactly. I was informed to be an editorial boards, so I contributed for editorial work of OMICS.
7. What is your greatest career accomplishment?
There are two. One is to make sure the formation mechanism of carcinogen from sterilized medical device. By this research I was awarded from Indian Society. The other is to confirm the superiority of the automated solid phase extraction (SPE)) compared with manual type SPE. By using automated SPE, I can publish reproducible analytical data using body fluids as a sample matrix.
8. How does the research published percolate through to practitioners?
As mentioned above, automated SPE is circulated and well known by my studies.
9. What is the purpose of serving as an editor?
I wish to polish up the OMICS J by my effort.
10. Do you have any patents?
Yes I have. This year I have one patent on gas plasma sterilization through the grant from Ministry of Economy, Trade and Industry.
11. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?
Yes, I have several papers. They are review, original and editorial.
12. Do you plan to contribute any editorials or papers to OMICS Journals in the next year?
Yes, I do, if necessary.
13. Do you have any trouble with OMICS Journals in the past?
Publication fee. It was over.
14. Would you recommend OMICS to your friends or colleagues?
The obstacle is the publication fee.
15. How do you differentiate Pharmaceutical Regulatory Affairs Journal with other journals in the field?
Pharmaceutical Regulatory Affairs deals with ISO, ICH, USP, JP and so on. The academic discussion will somewhat diminish compared with other research purpose.